Group items tagged

The Royal Pharmaceutical Society (RPS) has secured a contract with the National Institute for Health Research (NIHR) to deliver a suite of e-learning modules to help pharmacy professionals "become more research active". The new online resources - due to be launched next summer - are aimed at pharmacists and pharmacy technicians who may not have followed an academic career path or have had little or no experience of research delivery. The e-learning package will allow them to gain new skills so they feel more confident to engage with research and research opportunities. Nine modules are being developed covering how to transform ideas into a research project, find and evaluate evidence and choose the appropriate research methods whilst learning how to apply for research funding and deal with governance issues and publication.

The National Institute for Health and Care Excellence (NICE)'s independent committee has called for more research to ensure liposuction for treatment of chronic lipoedema is safe and effective enough for use on the NHS. Lipoedema is more prevalent in women and very rarely affects men. It is characterised by an abnormal, usually symmetrical, accumulation of fat in the legs, hips, buttocks, and occasionally arms. It is a separate condition to obesity and lymphoedema. The cause of lipoedema is unknown, but hormonal changes, weight gain and genetics are thought to be involved. The size and shape of legs, and the resultant mobility issues and pain, can have a profoundly negative effect on quality of life, and physical and mental health. The interventional procedures advisory committee reviewed evidence from several sources, including eight before-and-after studies. The committee was informed that several different liposuction techniques are used and that they may have different safety and efficacy profiles.

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised 'no one should stop taking valproate without advice from their healthcare professional.' The latest data on the use of valproate in England revealed that in the last 6 months the number of pregnant women prescribed valproate in a 6-month period has fallen from 68 women in April to September 2018, to 17 women in October 2021 to March 2022. In light of concerns that the current regulatory requirements for safe use are not being consistently followed, the MHRA conducted a review of the available data and asked for advice from the independent Commission on Human Medicines (CHM). "The CHM has advised that no one under the age of 55 should be initiated on valproate unless two specialists independently consider and document that there is no other effective or tolerated treatment," said MHRA. "Where possible, existing patients should be switched to another treatment unless two specialists independently consider and document that there is no other effective or tolerated treatment or the risks do not apply."

Find diet information and resources on the best fitness diet plans, diet plans and fitness plans.

Dr Syeda Batool Mazhar is very Expert to Deal with OBS and GYN Patients Dr. Syeda Batool is an alum of King Edward Medical College Lahore. She did her Specialization (FCPS) in Obs and Gyne in 2010 from The College of Phys and Surgeon Pakistan. She is also Member of the Royal College of OBS and GYN U.K. She has done her FRCOG, Fellow of the Royal College of OBS and GYN, U.K in 2005.At Present she is filling in as Dean of Nursing and Allied staff, SZABMU, since2016. Additionally she is Co-Chairperson RWP/ISB Chapter, Society of OBGYN, Pak since 2016. She is Chairperson OBGYN MCH Center, PIMS, SZABMU, Islamabad, since 2012. She was also Member of World Health Orignization (WHO) guiding council for examine on Madication-assisted Treatment (Mat) Health.she is likewise filling in as Consultant Gynecologist and Infertility Specialist at Australian Concept Infertility Medical Center Islamabad . Her uncommon advantages are Safe Motherhood, menopause and Infertility medicines.Dr Syeda Batool Mazhar Private Clinic is F8/3 Islamabad. https://fitnessfiestapro.blogspot.com/2020/03/pro-dr-syeda-batool-mazhar-consultant.html

Small Intestinal Bacterial Overgrowth (SIBO): Identification, Treatment and Prevention is organized by Dietitian Central. For More Info: https://www.emedevents.com/online-cme-courses/webcasts/small-intestinal-bacterial-overgrowth-sibo-identification-treatment-and-prevention

Asbestos poisoning is a serious health concern that can have long-lasting effects on your well-being. Exposure to asbestos fibers can lead to various health issues, including lung cancer, mesothelioma, and asbestosis. If you suspect that you've been exposed to asbestos or are experiencing symptoms related to asbestos poisoning, it's crucial to take immediate action. 1. Recognize the Symptoms The first step in dealing with asbestos poisoning is to recognize the symptoms. Common signs of asbestos exposure include shortness of breath, persistent coughing, chest pain, and fatigue. Additionally, you may experience respiratory issues such as wheezing or difficulty breathing. Exploring the use of asbestos at Honeywell in Massachusetts can help you get a better understanding of the potential risks associated with asbestos exposure and the importance of taking proactive measures to protect yourself and your loved ones from its harmful effects. It's essential to pay attention to any changes in your health and seek medical attention if you suspect asbestos exposure.

Community Pharmacy England (CPE) has reminded community pharmacy owners that the deadline to complete the 2023/24 Data Security and Protection Toolkit to make their information governance (IG) declaration is 30 June 2024. Sometimes referred to as the "NHS IG toolkit", the DSPT is a set of security requirements that companies are required to fulfill to supply goods and services to the health service to ensure the safety and protection of sensitive patient information. To help community pharmacy contractors complete the mandatory questions within the Toolkit, CPE on Monday (12 February) published new guidance, which also contains references to other useful materials. CPE is working with the NHS DSPTK team to keep the workload associated with Toolkit completion manageable whilst ensuring that appropriate data security protections are maintained. Pharmacy owners with three or more pharmacies can complete a single submission for all their premises through the NHS Parent Organisation Code (POC) headquarters (HQ) batch submission feature.

Local pharmacists in England can now evaluate and provide treatment for patients with uncomplicated urinary tract infections (UTIs) in women under the age of 65, without the need for a GP appointment. The 'ByeByeUTI' scheme has been expanded across the country, following a successful pilot across North East and North Cumbria. More than 30,000 women have been treated for uncomplicated urinary tract infections at local pharmacies since the pilot scheme was launched in July 2022 as part of the NHS and government's primary care access recovery plan, according to NHS England. The expansion of pharmacy services not only enhances patients' access to care but also frees up tens of thousands of GP appointments at the same time. Dr Faisel Baig, Medical Director for Primary Care, NHS England North East and Yorkshire, said that the rollout of this service across the whole region will enable many more women to receive "faster and easier" access to advice and treatment.

The Medicines and Healthcare products Regulatory Agency (MHRA) has reclassified codeine linctus, a medicine used for the treatment of dry cough, from a pharmacy-only medicine (P) to a prescription-only medicine (POM) owing to the risk of dependence, addiction, and overdose. This implies that the dry cough syrup, which is also known as codeine oral solution, can only be dispensed upon the submission of a prescription at a pharmacy, rather than being accessible over the counter upon request. Patients are cautioned that as an opioid medicine, codeine can be addictive, and the risk of addiction may increase, particularly with prolonged use over an extended period. According to the medicines regulator, codeine is converted into morphine by the liver enzyme CYP2D6. In individuals identified as ultra-rapid metabolizers, this conversion from codeine to morphine occurs at a faster rate than in others. "If you want to stop taking it and have been taking codeine linctus for a long time, then it is important to reduce the amount you take slowly with the help of your prescriber," the agency said in its drug safety update issued on Tuesday, 20 February.

The Royal Pharmaceutical Society (RPS) recently announced a valuable addition to their e-library collection: the Maudsley Deprescribing Guidelines, authored by renowned experts Mark Horowitz and David Taylor. Designed to assist pharmacists and clinicians in recognising and appropriately treating withdrawal effects of medications, the guidelines have garnered praise from industry figures like Peter Pratt, National Speciality Advisor for Mental Health Pharmacy and RPS Fellow. This initiative responds to the increasing demand for guidance on safely reducing or discontinuing psychiatric medications, providing comprehensive support for clinicians and patients alike. Drawing on insights from contributors to The Lancet Psychiatry, the handbook offers step-by-step instructions for tapering antidepressants, benzodiazepines, gabapentinoids, and z-drugs, along with troubleshooting strategies.

We've all heard of Dry January, but that doesn't mean that the first month of the year is the only one where you can quit the booze for an intermittent period. No, you can do it anytime and often it can be just the push you need to review your relationship with the hard stuff. More and more of us are developing problematic relationships with alcohol, and the likes of addiction are on the rise. Attempting an alcohol detox can be a good way to understand your relationship, although if you are heavily reliant on the substance, it is worth doing it in a controlled and safe environment with professional care. That said, for many of us that isn't the case and giving up for a month can see a wealth of changes in your life. So, what can you expect exactly? Improved Physical Health First and foremost, your physical health will improve as a result. Alcohol is known for its empty calories and sugar. It's why many of us develop beer bellys and gain weight when we drink regularly. Ultimately, by cutting those calories, you'll find it much easier to shed weight and the results can happen relatively quickly. What's more, as alcohol slows down metabolism and can often lead to poor food choices like takeaways, eliminating it makes it much easier to manage your weight.